Natixis’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
122,776
-202,021
-62% -$18M 0.04% 296
2025
Q4
$25.7M Buy
324,797
+6,364
+2% +$499K 0.09% 171
2025
Q3
$25.5M Buy
318,433
+169,382
+114% +$14.4M 0.12% 154
2025
Q2
$13.5M Sell
149,051
-21,369
-13% -$1.95M 0.06% 199
2025
Q1
$16M Sell
170,420
-19,747
-10% -$1.77M 0.09% 169
2024
Q4
$17.3M Buy
190,167
+38,829
+26% +$3.71M 0.11% 152
2024
Q3
$15.7M Buy
151,338
+13,340
+10% +$1.36M 0.09% 157
2024
Q2
$13.4M Sell
137,998
-317,290
-70% -$29.3M 0.08% 174
2024
Q1
$41M Buy
455,288
+452,838
+18,483% +$38.4M 0.21% 83
2023
Q4
$195K Sell
2,450
-484,824
-99% -$36.5M ﹤0.01% 722
2023
Q3
$34.7M Sell
487,274
-222,459
-31% -$16.6M 0.27% 84
2023
Q2
$54.7M Buy
709,733
+110,916
+19% +$8.59M 0.44% 42
2023
Q1
$45M Sell
598,817
-84,822
-12% -$6.31M 0.41% 53
2022
Q4
$53.9M Sell
683,639
-945,154
-58% -$70.9M 0.3% 84
2022
Q3
$115M Buy
1,628,793
+1,304,374
+402% +$102M 0.54% 28
2022
Q2
$26M Sell
324,419
-423,730
-57% -$33.1M 0.09% 137
2022
Q1
$56.7M Buy
748,149
+236,505
+46% +$18.7M 0.2% 110
2021
Q4
$43.4M Sell
511,644
-450,982
-47% -$35.2M 0.15% 128
2021
Q3
$72.8M Buy
962,626
+510,692
+113% +$40.6M 0.25% 75
2021
Q2
$36.8M Buy
451,934
+423,783
+1,505% +$34.7M 0.16% 131
2021
Q1
$2.22M Sell
28,151
-91,886
-77% -$7.2M 0.01% 674
2020
Q4
$10.3M Buy
120,037
+87,383
+268% +$7.23M 0.04% 385
2020
Q3
$2.52M Sell
32,654
-56,355
-63% -$4.3M 0.02% 379
2020
Q2
$6.52M Sell
89,009
-137,840
-61% -$9.79M 0.05% 247
2020
Q1
$15.1M Sell
226,849
-111,401
-33% -$7.86M 0.12% 158
2019
Q4
$23.3M Buy
338,250
+175,956
+108% +$12M 0.14% 170
2019
Q3
$11.9M Sell
162,294
-847,433
-84% -$61.5M 0.08% 235
2019
Q2
$72.4M Buy
1,009,727
+842,644
+504% +$59.8M 0.56% 43
2019
Q1
$11.3M Buy
167,083
+112,230
+205% +$7.25M 0.07% 257
2018
Q4
$3.27M Sell
54,853
-203,894
-79% -$12.8M 0.03% 381
2018
Q3
$17.3M Sell
258,747
-897,901
-78% -$59.8M 0.1% 194
2018
Q2
$74.5M Buy
1,156,648
+847,818
+275% +$55.5M 0.39% 68
2018
Q1
$22M Sell
308,830
-182,500
-37% -$13.1M 0.14% 165
2017
Q4
$37.1M Buy
491,330
+363,582
+285% +$26.5M 0.29% 95
2017
Q3
$9.31M Sell
127,748
-154,112
-55% -$11.1M 0.09% 204
2017
Q2
$20.9M Buy
281,860
+240,923
+589% +$17.9M 0.24% 106
2017
Q1
$3M Sell
40,937
-3,633
-8% -$254K 0.04% 271
2016
Q4
$2.92M Sell
44,570
-41,667
-48% -$2.86M 0.03% 308
2016
Q3
$6.39M Buy
+86,237
New +$6.37M 0.07% 171
2015
Q4
Sell
-30,583
Closed -$1.94M 320
2015
Q3
$1.94M Sell
30,583
-235,266
-88% -$15.4M 0.04% 131
2015
Q2
$17.4M Buy
265,849
+210,406
+379% +$14.3M 0.24% 80
2015
Q1
$3.84M Buy
55,443
+5,006
+10% +$346K 0.05% 144
2014
Q4
$3.49M Sell
50,437
-6,518
-11% -$440K 0.05% 148
2014
Q3
$3.71M Sell
56,955
-519,866
-90% -$34.3M 0.06% 167
2014
Q2
$39.3M Sell
576,821
-5,108
-0.9% -$342K 0.47% 52
2014
Q1
$37.8M Sell
581,929
-455,079
-44% -$28.7M 0.49% 54
2013
Q4
$67.6M Buy
1,037,008
+26,023
+3% +$1.67M 0.58% 36
2013
Q3
$60M Sell
1,010,985
-156,712
-13% -$9.28M 0.64% 40
2013
Q2
$66.9M Buy
+1,167,697
New +$69.3M 0.96% 21

Other funds holding CL

Natixis's CL Position: Q1 2026 in Review

Natixis reduced its Colgate-Palmolive (CL) stake by 62% in Q1 2026, selling an estimated $18M and leaving 122,776 shares worth $10.5M. The position accounts for 0.04% of the portfolio, ranked #296.

Natixis first reported a position in CL in Q2 2013 and has held it in 49 quarters since. The position peaked at $115M in Q3 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Natixis held 122,776 shares of Colgate-Palmolive worth $10.5M as of Q1 2026.
  • Natixis sold 202,021 Colgate-Palmolive shares in Q1 2026, an estimated $18M.
  • Colgate-Palmolive made up 0.04% of Natixis's portfolio in Q1 2026, its #296 holding.
  • Natixis first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 49 quarters since.
  • Natixis's Colgate-Palmolive position peaked at $115M in Q3 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.